ZANAGLIO, CAMILLA
 Distribuzione geografica
Continente #
NA - Nord America 1.121
EU - Europa 422
AS - Asia 159
AF - Africa 3
OC - Oceania 2
SA - Sud America 2
Totale 1.709
Nazione #
US - Stati Uniti d'America 1.110
IT - Italia 155
CN - Cina 96
UA - Ucraina 92
DE - Germania 51
FI - Finlandia 32
HK - Hong Kong 32
IE - Irlanda 29
SE - Svezia 24
GB - Regno Unito 17
IN - India 12
BE - Belgio 11
CA - Canada 10
FR - Francia 7
SG - Singapore 5
TR - Turchia 5
AU - Australia 2
BR - Brasile 2
GR - Grecia 2
JP - Giappone 2
MY - Malesia 2
TH - Thailandia 2
EG - Egitto 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
LV - Lettonia 1
MU - Mauritius 1
MX - Messico 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 1.709
Città #
Fairfield 194
Chandler 108
Ashburn 86
Jacksonville 76
Seattle 73
Wilmington 71
Woodbridge 71
Ann Arbor 69
Cambridge 54
Princeton 53
Houston 52
New York 47
Beijing 40
Brescia 32
Helsinki 32
Hong Kong 32
Dublin 27
Shanghai 13
Brussels 11
Pune 11
Des Moines 10
Nanjing 9
San Diego 7
Shenyang 7
Toronto 7
Genoa 6
Jinan 6
Darfo 5
Kocaeli 5
Rome 5
Battipaglia 4
London 4
Milan 4
Tianjin 4
Alzano Lombardo 3
Bologna 3
Brendola 3
Dearborn 3
Viterbo 3
Ancona 2
Casanova Lonati 2
Castleknock 2
Changsha 2
Chiswick 2
Guangzhou 2
Hebei 2
Lovere 2
Melbourne 2
Ningbo 2
Padova 2
Pescara 2
Shah Alam 2
São Paulo 2
Tokyo 2
Vicenza 2
Amman 1
Athens 1
Augusta 1
Bangkok 1
Brooklyn 1
Castiglione Delle Stiviere 1
Catania 1
Centurion 1
Chicago 1
Chieti 1
Civitavecchia 1
Falkenstein 1
Fiorenzuola D'arda 1
Gossolengo 1
Gîza 1
Haikou 1
Hangzhou 1
Hanover 1
Jiaxing 1
Kilburn 1
Kish 1
Kunming 1
La Spezia 1
Leawood 1
Lequio Tanaro 1
Los Angeles 1
Mcallen 1
Mexico City 1
Montecatini Terme 1
Nanchang 1
Nanterre 1
New Bedfont 1
North York 1
Norwalk 1
Orange 1
Pesaro 1
Porto 1
Redwood City 1
Riga 1
San Francisco 1
San Giorgio A Cremano 1
San Giuliano Milanese 1
Santa Clara 1
Spoltore 1
Stoney Creek 1
Totale 1.327
Nome #
Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary years 112
Feasibility of tumor‑derived exosome enrichment in the onco‑hematology leukemic model of chronic myeloid leukemia 112
Multidimensional Geriatric Assessment for Elderly Patients (≥60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients 102
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation 100
First Interim Report of the Italian Multicentric Phase-III Randomized Study to Optimize TKIs Multiple Approaches - (OPTkIMA) in Elderly Patients (older than 60 years) with Ph+ Chronic Myeloid Leukemia (CML) and MR3.0/ MR4.0 Stable Molecular Response 93
Comparative Somatic Mutational Profiling of CD34+ Hematopoietic Precursors (HSC) and Circulating Endothelial Cells (CEC) in Patients with Primary Myelofibrosis (PMF) 93
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 79
Identification of a Novel Mutation Predisposing to Familial AML and MDS Syndrome By a NGS Approach 77
RT-qPCR versus Digital PCR: How Do They Impact Differently on Clinical Management of Chronic Myeloid Leukemia Patients? 76
ETV6: A Candidate Gene for Predisposition to “Blend Pedigrees”? A Case Report from the NEXT-Famly Clinical Trial 73
Advances in CMV Management: A Single Center Real-Life Experience 72
Biological versus Clinical Risk Factors in Acute Myeloid Leukemia: Is There a Winner? 64
Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients 62
Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Level. Comparison of Qpcr, d-PCR and CD26 Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR) 60
Digital PCR (Dpcr) a Step Forward to Detection and Quantification of Minimal Residual Disease (MRD) in Ph+/BCR-ABL1 Chronic Myeloid Leukemia (CML) 59
OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 57
Safety and Efficacy of ATG-based GvHD prophylaxis in allogeneic stem cell transplantation for acute leukemia and myelodysplastic syndrome: a single center experience 55
DIGITAL PCR IN PH plus CHRONIC MYELOID LEUKEMIA PATIENTS FOR RECOGNITION OF "STABLE" DEEP MOLECULAR RESPONSE AND IDENTIFICATION OF BEST CANDIDATES TO TKI DISCONTINUATION 52
Comparative monitoring of deep molecular response (DMR) by RT-quantitative (RT-qPCR) and digital PCR (dPCR) in Ph+ Chronic Myeloid Leukemia (CML) patients treated with TKIs for recognition of stable deep molecular response (DMR) and identification of best candidates to TKIs treatment discontinuation. 51
Case Report: Late Onset of Myelodysplastic Syndrome From Donor Progenitor Cells After Allogeneic Stem Cell Transplantation. Which Lessons Can We Draw From the Reported Case? 44
Multidimensional geriatric assessment for elderly hematological patients (≥60 years) submitted to allogeneic stem cell transplantation. A French-Italian 10-year experience on 228 patients 43
dsDNA from extracellular vesicles (EVs) in adult AML 41
IN VIVO STUDY (MYCEC0617) OF CD34+-HSC AND CEC MUTATIONAL PROFILE FOR INVESTIGATING CELL ORIGIN AND PATHOGENESIS OF PRIMARY MYELOFIBROSIS (PMF) 40
Severe Acute Respiratory Syndrome Coronavirus-2 Pandemia: Facts and Perspectives in a Bone Marrow Transplant Unit 38
PF404 TUMOR-DERIVED EXOSOMES MAY BE USED AS NEW INFORMATIVE TOOL FOR THE DETECTION OF BONE MARROW RESIDUAL CML LEUKEMIC CELLS ACTIVITY 38
PS1540 MULTIPARAMETRIC PREDICTIVE SCORE FOR GRAFT VERSUS HOST DISEASE (GVHD) IN PATIENTS SUBMITTED TO ALLOGENEIC STEM CELLS TRANSPLANTATION (SCT) 35
S882 OPTIMIZATION OF TKI TREATMENT IN ELDERLY PATIENTS WITH PH+ CHRONIC MYELOID LEUKEMIA AND STABLE MR3.0 OR MR4.0: 1ST YEAR RESULTS OF THE ITALIAN MULTICENTRIC PHASE-III RANDOMIZED OPTKIMA STUDY 27
Totale 1.755
Categoria #
all - tutte 9.523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.523


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 0 10 9
2019/2020324 14 2 4 12 18 28 25 29 51 78 27 36
2020/2021561 14 32 19 95 30 77 29 62 52 79 40 32
2021/2022276 21 15 4 26 14 28 11 21 16 46 16 58
2022/2023299 39 15 14 20 22 57 2 49 44 7 16 14
2023/2024254 17 6 36 17 20 87 11 9 50 1 0 0
Totale 1.755